Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000345902

Medchemexpress LLC Quin C1 | 786706-21-6 | 98.5% | 445.51 | 25 MG
SDP

Catalog No. 5000345902
Encompass_Preferred

Quin C1 is a highly specific and potent agonist for formyl peptide receptor 2 (FPR2/ALX). Quin-C1 significantly reduces the neutrophil and lymphocyte counts in BALF, diminishes expression of TNF-α, IL-1β, KC, and TGF-β1, and decreases collagen deposition in lung tissue. Quin C1 has the potential for the research of lung injury.

  • Highly specific and potent agonist for formyl peptide receptor 2 (FPR2/ALX).
  • Significantly reduces neutrophil and lymphocyte counts in BALF.
  • Diminishes expression of TNF-α, IL-1β, KC, and TGF-β1.
  • Decreases collagen deposition in lung tissue.
  • Potential for research of lung injury.

Catalog No. 50-003-45902 Supplier Medchemexpress LLC Supplier No. 25MGHY110246
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Quin C1 is a highly specific and potent agonist for formyl peptide receptor 2 (FPR2/ALX). Quin-C1 significantly reduces the neutrophil and lymphocyte counts in BALF, diminishes expression of TNF-α, IL-1β, KC, and TGF-β1, and decreases collagen deposition in lung tissue. Quin C1 has the potential for the research of lung injury.

  • Highly specific and potent agonist for formyl peptide receptor 2 (FPR2/ALX).
  • Significantly reduces neutrophil and lymphocyte counts in BALF.
  • Diminishes expression of TNF-α, IL-1β, KC, and TGF-β1.
  • Decreases collagen deposition in lung tissue.
  • Potential for research of lung injury.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.